HomeAI · summaries
Storia in 3 fonti
Centre intensifies regulatory surveillance over weight loss drugs
India intensifies regulatory measures on weight loss drugs to prevent unauthorized sales and ensure safe medical use.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top
Indian generic drugmakers launch a price war against Novo Nordisk’s GLP-1 brands, Ozempic and WeGovy.
- ·
arabnews.com
India warns of misuse risk from cheap weight-loss jabs
India’s health ministry warned Tuesday of the risks of unregulated use of weight-loss drugs, as low-cost generic versions hit the market, stepping up inspections and enforcement…
